Carcinogenesis is more common in DC patients carrying mutations in TERT and TERC compared to TINF2. Unfortunately, TINF2-mutated patients generally display poor outcome due to the severity of the disease, regardless of cancer [124]. This evidence concerns the gene TINF2 and cancer.